Proteomics of gliomas: initial biomarker discovery and evolution of technology. - Wikidata - awgldk - TriplyDB

Proteomics of gliomas: initial biomarker discovery and evolution of technology.

Proteomics of gliomas: initial biomarker discovery and evolution of technology.

http://www.wikidata.org/entity/Q35170365

about

Circulating glioma biomarkers A review of novel analytical diagnostics for liquid biopsies: spectroscopic and spectrometric serum profiling of primary and secondary brain tumors Identification of novel tumor-associated cell surface sialoglycoproteins in human glioblastoma tumors using quantitative proteomics Discovery of colorectal cancer biomarker candidates by membrane proteomic analysis and subsequent verification using selected reaction monitoring (SRM) and tissue microarray (TMA) analysis Identification of plasma biomarker candidates in glioblastoma using an antibody-array-based proteomic approach SurvNet: a web server for identifying network-based biomarkers that most correlate with patient survival data.Potential serum biomarkers for glioblastoma diagnostic assessed by proteomic approaches.Circulating serum trefoil factor 3 (TFF3) is dramatically increased in chronic kidney disease.Total protein is an effective loading control for cerebrospinal fluid western blots Comprehensive characterization of glioblastoma tumor tissues for biomarker identification using mass spectrometry-based label-free quantitative proteomics Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localization Advances in the proteomic discovery of novel therapeutic targets in cancer.Differential proteomics analysis of low- and high-grade of astrocytoma using iTRAQ quantification The molecular landscape of diffuse glioma and prospects for biomarker development.Proteomic analysis of cerebrospinal fluid: toward the identification of biomarkers for gliomas.Towards developing biomarkers for glioblastoma multiforme: a proteomics view.Circulating biomarker panels for targeted therapy in brain tumors.Beyond the World Health Organization grading of infiltrating gliomas: advances in the molecular genetics of glioma classification.MicroRNA-26a promotes tumor growth and angiogenesis in glioma by directly targeting prohibitin.Identification of Plasma Membrane Glycoproteins Specific to Human Glioblastoma Multiforme Cells Using Lectin Arrays and LC-MS/MS.Cerebrospinal fluid and serum IL-8, CCL2, and ICAM-1 concentrations in astrocytic brain tumor patients.BICD1 expression, as a potential biomarker for prognosis and predicting response to therapy in patients with glioblastomas.Proteomic approaches in biomarker discovery: new perspectives in cancer diagnostics.Enhanced proteasomal activity is essential for long term survival and recurrence of innately radiation resistant residual glioblastoma cells.

P2860

Q26830329-4CD1D579-5465-449C-947B-3032B0FEA318 Q28069912-5E674674-05F6-4BBE-BF31-C20D8209C53E Q28544645-E0358C3A-CBAF-458B-9895-AFB96DFE8FF3 Q33718710-E5AF5D52-B2AF-48DF-A21D-95F481578C33 Q33946339-65575FEF-8031-485A-9A9C-9C9877399C45 Q34262900-4B5B1DD1-D67A-468D-AD8B-7895DF965D07 Q34305848-41E764FF-1A3E-4BE3-9ECB-1DF4D4B95FEB Q35055099-0FE5A387-D0F2-4DAE-91EE-6AC2F0D2A2E8 Q35966833-5B68CB28-3D44-4ACA-976B-8AD11E19D179 Q36104523-FC9F8CA2-6383-4F97-BDF8-7972F1479182 Q36578825-6F82CCD0-133F-4C32-B8BA-B0FC8F82A993 Q37260569-7D4E8301-BFB2-4A2B-807A-D6864DD33B8D Q37301385-F0776999-D321-4D2B-91BB-667CE25B25CC Q38155656-BC6BE4CC-1C40-4253-B507-8E812F196435 Q38208182-D65870AF-7C57-4B6F-B255-7138076BAD4B Q38239173-7C48428C-28B5-433E-B384-56409CB63171 Q38252948-7EE41BBF-C79B-4774-8EA7-84145E360EC0 Q38504172-106D4AFD-16BC-4B0F-BDF3-575F294F6739 Q39123359-ABDCC9F0-264D-4749-9234-A250A208C6E1 Q47349973-A4258B4F-29D4-4BB9-AB0A-79DEC072BF30 Q47584968-A958F158-23E4-4EF6-93EE-DB8A49998F01 Q49640790-FB5FEF32-E53E-43B0-9FAD-C22183D7FF95 Q54962725-3237A5A6-5CD7-42C8-90C4-1DC622A4749A Q55379488-7772B54D-267C-4259-AE3D-18E42FECC1C1

P2860

Proteomics of gliomas: initial biomarker discovery and evolution of technology.

http://www.wikidata.org/entity/Q35170365

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Proteomics of gliomas: initial biomarker discovery and evolution of technology.

@ast

Proteomics of gliomas: initial biomarker discovery and evolution of technology.

@en

type

label

Proteomics of gliomas: initial biomarker discovery and evolution of technology.

@ast

Proteomics of gliomas: initial biomarker discovery and evolution of technology.

@en

prefLabel

Proteomics of gliomas: initial biomarker discovery and evolution of technology.

@ast

Proteomics of gliomas: initial biomarker discovery and evolution of technology.

@en

P1433

Q35170365-56C38D18-9DB1-457A-9D0D-9EBEED31F20E

P1476

Q35170365-E8105DAA-E8F6-4C1C-9B41-3962E43B1A57

P2093

Q35170365-B527C93A-BC3C-4BF7-BCC4-53D824ADC3ED

Q35170365-E868B8AB-6FFC-48F8-85FA-9A8D806B8894

Q35170365-F8977710-E7EE-4F67-8EE3-ED8E221E53E1

P2860

Q35170365-01F35970-6DD2-497C-B5C6-6ED307516FC1

Q35170365-055881CF-FCE2-45AB-8085-7B730286A56A

Q35170365-0585C335-37D8-4E7F-9D7F-9FD3031AC31E

Q35170365-0AE109CA-4242-42E7-8B10-8EBC22F50231

Q35170365-0AE7F3E2-47B6-40BF-B7FA-776977385CC6

Q35170365-0F73BBDA-F14E-4EAE-88A9-80A97A472585

Q35170365-0FC6DEC8-4309-431A-A471-83F2FE3F55F9

Q35170365-147054DA-0FA4-4F04-A98B-17FD18E64477

Q35170365-17695E17-418F-4397-83B1-5D364E26248B

Q35170365-185C310A-F2AD-436D-ABA8-D60A0583CEAC

P304

Q35170365-38920A77-93BA-4D48-8656-A08770A5DC16

P31

Q35170365-F451645D-8CF6-44D2-965D-50D88C901418

P356

Q35170365-C9D240C8-0F95-40D1-9060-6CA2C7C8102A

P433

Q35170365-8FFA87DB-5A7B-49DA-806E-C66DAF0661BD

P478

Q35170365-C9CF26DA-8118-49FD-8D9B-5C5711AE1F58

P50

Q35170365-65629859-4F1C-4929-8B59-E48B92A1F74C

P577

Q35170365-3588A4EE-2C22-4252-BDE7-98B3965D9FE5

P5875

Q35170365-9583E54C-ABE9-4059-B0A3-9EA3F93F120E

P698

Q35170365-25BD94DB-C0B8-4595-8EF3-9F27AE7D7369

P921

Q35170365-2E93617F-78E3-4A25-9F5F-550C421706A9

P932

Q35170365-D995F30C-6BFB-42E3-A764-8CCA41624BC3

P356

P1433

P1476

Proteomics of gliomas: initial biomarker discovery and evolution of technology.

@en

P2093

James C Ritchie

http://www.w3.org/2001/XMLSchema#string

Juliya Kalinina

http://www.w3.org/2001/XMLSchema#string

Junmin Peng

http://www.w3.org/2001/XMLSchema#string

P2860

Human cerebrospinal fluid peptidomics

Clinical features of chronic hepatitis B patients with YMDD mutation after lamivudine therapy.

Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers

Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

The 2007 WHO classification of tumours of the central nervous system

Large-scale analysis of the yeast proteome by multidimensional protein identification technology

Quantitative analysis of complex protein mixtures using isotope-coded affinity tags

Mass spectrometry-based proteomics

Proteomics-based identification of differentially expressed genes in human gliomas: down-regulation of SIRT2 gene

P304

926-942

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NEUONC/NOR078

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Erwin G Van Meir

P577

2011-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51581555

http://www.w3.org/2001/XMLSchema#string

P698

21852429

http://www.w3.org/2001/XMLSchema#string

P921

P932

3158015

http://www.w3.org/2001/XMLSchema#string